Member Info for Palmsairport

If MHC have been slow to react to the speed with which events have developed, you would assume that they are avidly reviewing the situation with regards to launching of products as we write. Let's hope the income, which was phenomenal for the company, is being used wisely and appropriately to consolidate its future development. Still, on the PCR front, the sentiment among the scientific community is that the testing should not be compromised so things could change again quickly.
'Alan McNally is Professor of Microbial Evolutionary Genomics at the University of Birmingham, which set up a so-called Lighthouse lab, a facility dedicated to PCR testing, at the beginning of the pandemic. He tells BBC Radio 4's Today programme: "If you look at the rates of Covid in the UK now they’re high, so probably lateral flow testing will be sufficient for travellers.
"But I don’t think we can just completely remove all controls on travel… we know from the past that travel-associated Covid is very high risk for this country."He says he hopes for a “very strong mandate” that any positive lateral flow tests are followed by a PCR test to detect variants.
“We still need that genome level surveillance of Covid cases being introduced into the UK from abroad,”
https://www.bbc.co.uk/news/live/uk-58593572
https://www.birmingham.ac.uk/news/latest/2020/10/government-covid-19-testing-lab-to-open-at-the-university-of-birmingham.aspx

Excellent points LondonMarket and indeed as you highlighted the CEO's reference to its being a “Global issue, not just down to what UK would /like/ to do”, remains entirely valid; many countries require a 'negative PCR test within 72 hours before arrival' https://www.gov.uk/foreign-travel-advice and the unpredictability of the whole situation means that things could change very rapidly.

I think many of us watched this interview back in early August, but given the events of the last few days, it is worth listening to again as its very relevant to the question of the prospects, ambitions and long term goals of the company.

What is the focus for myhealthchecked in a post-pandemic world? (5.14 s onwards)
'The future for myhealthchecked has not changed: we are a wellness business that has got an exciting future ahead of us with new tests coming into the market'

https://www.brrmedia.co.uk/broadcasts/610a9cb42379e74e98fa9c4b/myhealthchecked-an-introduction/

'Plans to scrap PCR tests for most people coming into the country leaves the UK "flying blind as the pandemic rages", a top scientist has warned. The government's proposals to ditch the tests for double-vaccinated arrivals have been strongly criticised by Richard Horton, editor-in-chief of the medical journal the Lancet. He has warned that the UK is "on a knife's edge" in its pandemic response, and making a wrong move now could be disastrous.

https://www.mirror.co.uk/news/uk-news/uk-flying-blind-perfect-storm-24971520

Rktech 'Jack Bai could have funded that with his own petty cash and if the company is going to do what it's putting on the tin why give away that amount of equity for peanuts.'

These are the exact questions I was asking myself. As you said, on the surface, it seems like it's giving away so much for so little, unless of course, there are more compelling reasons for GST's pursuing such a route.

Thanks JiffyBag. I did not spot that so perhaps an email to the company stating that the prospectus mentioned 'GSF UK is currently in the process of seeking to obtain an Authorised Payment Institution ("API") licence from
the Financial Conduct Authority in the UK (“FCA”) and expects that process to conclude within the next four to
five', but then point out to them that there is an omission as it does not specify whether this is referring to weeks or months. They should be obliged to reply, especially as it is obviously an unintended oversight.

I think everyone agrees the potential is definitely there. In the RNS, it mentioned 'Should that licence be obtained' and I was wondering how would not obtaining a license affect the company's overall strategy and development.

Tone Goh, Chairman of GST, commented: 'I look forward to providing further updates in due course as we seek to rapidly build a blockchain enabled neobanking business'.
Split infinitives aside, I hope that 'rapidly' really means that.

"Yup, I've read that RNS quite a few times. It states their intent to apply, but does not say that they have filed an application".
How right you were PM22. All this time and they have not even submitted an application.

This is from the RNS of the 5th of March:
'Additionally, the Company's wholly owned subsidiary GS Fintech Ltd, in UK, intends to shortly file an application with the Financial Conduct Authority ("FCA") to be granted an Authorised Payment Institution ("API") licence. Should an API licence be granted it will provide the Company with the rights to connect to established payment gateways and commence a remittance business in the UK, which the Company intends to underpin by blockchain technology and its existing capabilities'.

It's the long term view that matters and in such a context the share has been following a consistently rising pattern. With all the news flow to come, that pattern of ascent will continue to dominate over the months ahead.

Very strong fundamentals at work here and these are further confirmed by the technical analysis.

https://www.share-talk.com/traders-cafe-with-zak-mir-bank-holiday-bulletin-board-heroes-sunday-29th-august-2021-via-vox-markets/#gs.a9l65m

2.30 secs (described as one of the 'stockmarket darlings of the year')

'Energy producers, particularly those on federal land and waters, in the United States are subject to among the highest environmental standards in the world'

https://www.energy.senate.gov/2021/8/senators-to-president-biden-why-are-you-favoring

FrankiesFortune
I think it is prudent to be cautious with predictions and somewhere around the figure you mentioned makes sense. Still, I recall looking at the FT forecast for this share back in January 2021 and 22p was the figure the one analyst offered for a 12 month price target back then. It remains unchanged. Interestingly, that was just after the company was added to the UK Government's approved COVID-19 private testing list (29th of December 2020). Of course, some months after that the Boots deal was announced in early April and then much later the Nell Health acquisition was announced in June. If they can use the revenue from the COVID-19 tests wisely to develop and launch products, then the prospects look very good.
https://markets.ft.com/data/equities/tearsheet/forecasts?s=MHC:LSE

sorry Gareth

Dr. Gavin Cave is one of the contributors to this academic study: 'Vitamin B12 (cobalamin) and micronutrient fortification in food crops using nanoparticle technology'. The uses for this technology are impressive.

http://irep.ntu.ac.uk/id/eprint/44087/

The website states that:
'We intend to become the first and only issuer, and service provider of stablecoins (a form of e-money token) listed on the London Stock Exchange'. Adding that 'Blockchain technology enables more open, inclusive, and secure business networks, more efficient processes, reduced costs, and new products and services in payments, banking and finance'.
If GST is able to achieve its objectives, it seems reasonable to assume that the rewards will be well worth the wait.
https://www.gstechnologies.co.uk/gsfintech

Thanks again AG1989: just watching through the Dec 2020 interview with Bert Monro, the record thus far unquestionably confirms that this is a distinct case of delivering and achieving even more than what 'they planned to do'.
https://www.youtube.com/watch?v=buGkEI8w6VI

Covid-19 impact: No import duty on ventilators, masks, other key medical equipment for six months
Our Bureau New Delhi | Updated on April 10, 2020

https://www.thehindubusinessline.com/economy/policy/covid-19-impact-no-import-duty-key-medical-equipments-for-six-months/article31305339.ece

https://www.gov.uk/government/news/cma-warns-pcr-test-providers-against-breaking-consumer-law

As the CEO PennyMcCormick said in the recent RNS, 'We welcome the Health Secretary's call for the competition watchdog to investigate concerns about inadequate service', but it seems too lenient to adopt a 'two strike' and you're out policy for these rogue providers.